A lot of women have resorted to hormonal therapy to ease troubling menopause symptoms of night sweats and hot flashes. However, new research has suggested that this relief may be accompanied by a heavy cost of contracting increased Alzheimer’s disease’s risk.
This study unearthed that women who have gone through hormone therapy showed a 9-17% greater risk of development of Alzheimer’s disease. Especially women who started to take hormone therapy prior to reaching 60 years of age, this elevated risk was found to be connected to a long-term usage ranging a decade or greater.
According to Dr. Tomi Mikkola, the takeaway from this study, when expressed as absolute terms, is that 9–18 extra Alzheimer’s disease diagnoses will be found annually in a sample size of 10,000 women with an age range of 70-80, particularly in women who’d already been on hormonal therapy for a time period exceeding 10 years. Mikkola is the senior author of this particular study. He is appointed at the associate professor position in the gynecology and obstetrics department in Finland’s University Hospital of Helsinki. The study had been published online in BMJ on March 6, accompanied by an editorial.
Dr. JoAnn Manson, who is one of the authors to have penned this editorial, has assured that the reports arising from this particular study are not a cause of alarm in any way. Manson is the preventive medicine division’s chief at Boston’s Brigham and Women’s Hospital.
According to her, the research results have large been able to reassure younger women who are going through early stages of menopause, if these women are looking to seek treatment for hot flashes night sweats. Using the evidence totality as the basis, a reason to believe in hormone therapy being relatively safe for women still in the early stages of menopause, has been established.